We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

My Personal Therapeutics Announces Funding and Secures Exclusive Mount Sinai School of Medicine Technology License to Revolutionize Personalized Cancer Treatment

Product News   Apr 30, 2019

 
My Personal Therapeutics Announces Funding and Secures Exclusive Mount Sinai School of Medicine Technology License to Revolutionize Personalized Cancer Treatment

The Personal Discovery Process (PDP)

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Mission Bio Launches Cloud-based Tool to Improve CRISPR Safety

Product News

Mission Bio has extended capabilities for its automated, cloud-based tool for designing targeted single-cell DNA custom panels, now with applications across mouse genomes and CRISPR editing.

READ MORE

Specialized MAT Reagents for Accurate and Reliable In Vitro Pyrogen Testing

Product News

Lonza and Sanquin have entered into a strategic partnership for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the Monocyte Activation Test.

READ MORE

Miltenyi Biotec Launches Fully Automated Light Sheet Microscope

Product News

Miltenyi Biotec has announced the UltraMicroscope Blaze, the world’s first fully automated light sheet microscope.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE